Large trans-ethnic meta-analysis identifies AKR1C4 as a novel gene associated with age at menarche

• Published in: Human reproduction (Oxford) Vol. 36; no. 7; pp. 1999 - 2010
• Main Authors: Sarnowski, C, Cousminer, D L, Franceschini, N, Raffield, L M, Jia, G, Fernández-Rhodes, L, Grant, S F A, Hakonarson, H, Lange, L A, Long, J, Sofer, T, Tao, R, Wallace, R B, Wong, Q, Zirpoli, G, Boerwinkle, E, Bradfield, J P, Correa, A, Kooperberg, C L, North, K E, Palmer, J R, Zemel, B S, Zheng, W, Murabito, J M, Lunetta, K L
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 18-06-2021
• Subjects: Adolescent; Cohort Studies; Ethnicity; Female; Genome-Wide Association Study; Humans; Menarche - genetics; Original; Polymorphism, Single Nucleotide; ReproGen Consortium; GWAS; trans-ethnic meta-analysis; AKR1C4; age at menarche; UK Biobank
• ISSN: 0268-1161; 1460-2350; 1460-2350
• DOI: 10.1093/humrep/deab086

Does the expansion of genome-wide association studies (GWAS) to a broader range of ancestries improve the ability to identify and generalise variants associated with age at menarche (AAM) in European populations to a wider range of world populations?
By including women with diverse and predominantly non-European ancestry in a large-scale meta-analysis of AAM with half of the women being of African ancestry, we identified a new locus associated with AAM in African-ancestry participants, and generalised loci from GWAS of European ancestry individuals.
AAM is a highly polygenic puberty trait associated with various diseases later in life. Both AAM and diseases associated with puberty timing vary by race or ethnicity. The majority of GWAS of AAM have been performed in European ancestry women.
We analysed a total of 38 546 women who did not have predominantly European ancestry backgrounds: 25 149 women from seven studies from the ReproGen Consortium and 13 397 women from the UK Biobank. In addition, we used an independent sample of 5148 African-ancestry women from the Southern Community Cohort Study (SCCS) for replication.
Each AAM GWAS was performed by study and ancestry or ethnic group using linear regression models adjusted for birth year and study-specific covariates. ReproGen and UK Biobank results were meta-analysed using an inverse variance-weighted average method. A trans-ethnic meta-analysis was also carried out to assess heterogeneity due to different ancestry.
We observed consistent direction and effect sizes between our meta-analysis and the largest GWAS conducted in European or Asian ancestry women. We validated four AAM loci (1p31, 6q16, 6q22 and 9q31) with common genetic variants at P < 5 × 10-7. We detected one new association (10p15) at P < 5 × 10-8 with a low-frequency genetic variant lying in AKR1C4, which was replicated in an independent sample. This gene belongs to a family of enzymes that regulate the metabolism of steroid hormones and have been implicated in the pathophysiology of uterine diseases. The genetic variant in the new locus is more frequent in African-ancestry participants, and has a very low frequency in Asian or European-ancestry individuals.
N/A.
Extreme AAM (<9 years or >18 years) were excluded from analysis. Women may not fully recall their AAM as most of the studies were conducted many years later. Further studies in women with diverse and predominantly non-European ancestry are needed to confirm and extend these findings, but the availability of such replication samples is limited.
Expanding association studies to a broader range of ancestries or ethnicities may improve the identification of new genetic variants associated with complex diseases or traits and the generalisation of variants from European-ancestry studies to a wider range of world populations.
Funding was provided by CHARGE Consortium grant R01HL105756-07: Gene Discovery For CVD and Aging Phenotypes and by the NIH grant U24AG051129 awarded by the National Institute on Aging (NIA). The authors have no conflict of interest to declare.